Institutional Ownership
Drugs Made In Amer Acq II Co
CUSIP G2851K120UNIT 09/16/2030Q1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lmr Partners LLP | 2.00M | $20.08M |
| 2 | Westchester Capital Management, LLC | 502.9K | $5.05M |
| 3 | Tig Advisors, LLC | 500.0K | $5.02M |
| 4 | Verition Fund Management LLC | 250.0K | $2.51M |
| 5 | Bluecrest Capital Management Ltd | 250.0K | $2.51M |
| 6 | Clear Street Group Inc. | 166.6K | $1.67M |
| 7 | Walleye Capital LLC | 100.0K | $1.00M |
| 8 | L1 Global Manager Pty Ltd | 100.0K | $1.00M |
| 9 | Readystate Asset Management LP | 100.0K | $1.00M |
| 10 | Rangeley Capital, LLC | 55.6K | $326.8K |